Senda Ajroud-Driss – Grants — Northwestern Scholars

View Scopus Profile

Emails-ajroudnorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

27 Finished
36 Active

25 - 50 out of 63 results

Active

Cost Reimbursement
Ajroud-Driss, S.
Massachusetts General Hospital
3/23/20 → 12/31/22
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) C to Master Protocol CNM-Au8 | Double-Blind Phase
Ajroud-Driss, S.
Massachusetts General Hospital
3/23/20 → 12/31/22
Project: Research project
HEALEY ALS Platform Trial Platform-Level Site Activities
Ajroud-Driss, S.
Massachusetts General Hospital
3/23/20 → 12/31/22
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) B to Master Protocol Verdiperstat | Double-Blind Phase
Ajroud-Driss, S.
Massachusetts General Hospital
2/26/20 → 12/31/22
Project: Research project
Cost Reimbursement
Ajroud-Driss, S.
Massachusetts General Hospital
2/26/20 → 12/31/22
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) A to Master Protocol ZILUCOPLAN | Double-Blind Phase
Ajroud-Driss, S.
Massachusetts General Hospital
2/7/20 → 12/31/22
Project: Research project
Prot:ALXN1210-MG-306: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
Ajroud-Driss, S.
INC Research, LLC, Alexion Pharmaceuticals, Inc.
1/17/20 → 1/17/23
Project: Research project
Master Clinical Trial Agreement - HEALEY ALS Platform Trial
Ajroud-Driss, S.
Massachusetts General Hospital
12/5/19 → 12/4/24
Project: Research project
Prot# ALN-TTRSC02-002: HELIOS-A: A Phase 3 Global, Randomized, Open-label Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis(hATTR Amyloidosis)
Ajroud-Driss, S.
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
2/22/19 → 2/24/23
Project: Research project
Consortium Member and Peripheral Neuropathy Research Registry Agreement
Ajroud-Driss, S.
Foundation for Peripheral Neuropathy
1/1/18 → 12/31/22
Project: Research project
Prot #ALN-TTR02-006: A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy who have Completed a Prior Clinical Study with Patisiran
Ajroud-Driss, S.
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
2/18/16 → 2/20/23
Project: Research project
Finished
PLS Natural History Study
Ajroud-Driss, S.
Columbia University, Spastic Paraplegia Foundation, Inc.
7/15/20 → 7/14/22
Project: Research project
Natural History Pilot Project
Ajroud-Driss, S.
ALS Association
1/1/20 → 9/30/20
Project: Research project
Answer ALS: Return of ALS Results (RoAR)
Ajroud-Driss, S.
Ohio State University, Johns Hopkins University
1/1/20 → 6/1/20
Project: Research project
Prot# 3119003: Effects of Oral Levosimendan(ODM-109) on Respiratory Funcation in Patients with ALS: Open-Label Extension for Patients Completing Study 3119002
Ajroud-Driss, S.
Pharmaceutical Research Associates, Inc., Orion Group
7/19/19 → 7/19/22
Project: Research project
Prot #3119002: Effects of Oral Levosimendan(ODM-109) on Respiratory Function in Patients with ALS
Ajroud-Driss, S.
PRA Health Sciences, Orion Group
5/31/18 → 11/30/21
Project: Research project
Prot#ISIS 420915-CS5:Expanded Access Program for Inotersen (ISIS 420915) in Patients with Hereditary Transthyretin Amyloidosis (hATTR)
Ajroud-Driss, S.
Clinigen Inc., Ionis Pharmaceuticals, Inc.
3/26/18 → 3/26/21
Project: Research project
Answer ALS: Individualized Initiative for ALS Discovery
Ajroud-Driss, S.
Johns Hopkins University, Les Turner Amyotrophic Lateral Sclerosis Foundation, Ltd.
1/1/18 → 12/31/21
Project: Research project
Protocol ALN-TTR02-007: Expanded Access Protocol of Patisiran for Patients with Hereditary Transthyretin-Mediated Amyloidosis (hATTR Amyloidosis) With Polyneuropathy
Ajroud-Driss, S.
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
7/20/17 → 7/20/20
Project: Research project
Prot# VMDN-003 / A: A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study To Assess The Safety And Efficacy Of VM202 In Subjects with Painful Diabetic Peripheral Neuropathy
Ajroud-Driss, S.
ViroMed Co., Ltd.
8/11/16 → 8/11/20
Project: Research project
Prot #AHS1-13-001: Intravenous Immunoglobulin (IVIg) Treatment Related Fluctuations in Chronic Inflammatory Demyelinating Polyneuropathy (CDIP) Patients Using Daily Grip Strength Measurements (GRIPPER)
Ajroud-Driss, S.
University of Minnesota, CSL Behring
1/21/16 → 12/31/17
Project: Research project
Neuroimaging Symposium in ALS
Ajroud-Driss, S.
ViroMed Co., Ltd.
8/1/15 → 7/31/16
Project: Research project
CBAF312X2205: A Multi-Centre, Double-Blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients with Polymyositis
Ajroud-Driss, S.
Novartis Pharmaceuticals Corporation
6/26/15 → 3/31/17
Project: Research project
NN103: A Phase II Trial of Rituximab In Myasthenia Gravis
Ajroud-Driss, S.
Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke
10/1/14 → 7/31/17
Project: Research project
ALN-TTR02-004 – “APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ALN-TTR02 in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)”
Ajroud-Driss, S.
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
4/17/14 → 1/31/18
Project: Research project